Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The...

52
Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center

Transcript of Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The...

Page 1: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Sedative-Hypnotic Drugs

Marina Bergman PharmD PhD

Lecturer Clinical Generalist – Pharmacist

The Ohio State University Wexner Medical Center

Page 2: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

What a drag it is getting old "Kids are different today" I hear ev'ry mother say Mother needs something today to calm her down And though she's not really ill There's a little yellow pill She goes running for the shelter of a mother's little helper And it helps her on her way, gets her through her busy day

Little Yellow Pill

Page 3: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Objectives• Identify the major chemical classes of sedative-hypnotics.• Describe the pharmacodynamic of benzodiazepines and 

barbiturates, including their mechanisms of action.• Compare the pharmacokinetics of commonly used 

benzodiazepines and barbiturates and discuss how differences among them affect clinical use.

• Describe the clinical uses and the adverse effects of sedative hypnotics.Identify the distinctive properties of buspirone, zolpidem eszopiclone , ramelteon and zaleplon.

Page 4: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Overview

• Anxiety – a state of tension, apprehension uneasiness.

• Sedative (anxiolytic) - agent that reduces anxiety

• Hypnotic - drug that induces sleep• Benzodiazepines (BZs)- widely used

sedative-hypnotics• Barbiturates- anxiolytics at low doses,

hypnotics at high doses

Page 5: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Learning Resource

• Trevor AJ and Way WL, Sedative-Hypnotic Drugs, in Basic and Clinical Pharmacology, Katzung BG, Master SB, McGraw-Hill Lange, New York 2012.

Page 6: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Benzodiazepines (BZs)

• Sedative (anxiolytics) – alprazolam, clorazepate chlordiazepoxide, diazepam, halazepam, lorazepam, oxazepam

• Hypnotics – estezolam, lorazepam, quazepam, temazepam, triazolam

Page 7: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Safety

Page 8: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Chemical Structures of Benzodiazepines

Page 9: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Mechanism of Action

• Receptor for BZs are found in many Brain regions

• Binding of BZs to the GABAA receptor promotes the inhibitory action of GABA

• BZs increase the frequency of GABA mediated chloride ion channel opening

Page 10: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

gamma–Aminobutyric Acid GABA-alpha Receptor

Page 11: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Receptor Empty(No Agonists)

GABA receptor

Chloride Channel closed

+ + + +

- - - -

+ + + +

- - - -

Benzodiazepine site

Cl-

Empty receptor is inactive, and the coupled chloride channel is closed.

GABAA receptors are composed of , , subunit families of which a combination of five or more span the postsynaptic membrane and surround a chloride channel.

Fig 1A Mechanism of action of GABA and benzodiazepines

Page 12: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

GABA receptor

+ + + +

- - - -

+ + + +

- - - -

Benzodiazepine site

GABA

GABA

Cl-

Cl-

Binding of GABA causes chloride channel to open

Fig 1B Mechanism of action of GABA and benzodiazepines

Page 13: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

GABA receptor

+++++++

--------------

+++++++

--------------

GABA

Cl-

Cl- Cl-

Cl-Cl-

Cl-

Benzodiazepine

Entry of chloride ions hyperpolarizes cell, making it difficult to depolarize and thus reducing neural excitability

Benzodiazepines modulate the GABA effects by binding to their receptors near  and 2  subunits of GABAA receptor, thus increasing further the chloride influx.

Binding of GABA is enhanced by 

benzodiazepine, resulting in a greater entry of chloride ion 

Fig 1C Mechanism of action of GABA and benzodiazepines

Page 14: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Pharmacological Action of BZs

• Sedation (antianxiety)• Hypnosis• Anticonvulsant• Muscle relaxant• Amnesia

Page 15: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Duration of Action of Benzodiazepines

Page 16: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Therapeutic Uses

• Anxiety disorders• Sleep disorders• Muscular disorders• Seizures• Anesthesia

Page 17: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Anxiety Disorders

• BZ’s are effective for the treatment of the anxiety symptoms due to depression schizophrenia, panic disorders, social anxiety disorder, GAD, performance anxiety, post traumatic stress disorder, OCD, phobias

• The anti-anxiety effect of BZ’s is less subjective to tolerance

• Long acting agents are preferred, (e.g. lorazepam, diazepam, alprazolam)

Page 18: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Sleep disorders

• Flurazepam – reduces sleep-induction time and awakening

• Temazepam – used for pt w/ inability to stay asleep

• Triazolam – recurring insomnia, tolerance, rebound insomnia

Page 19: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Muscular disorders

Diazepam - muscle spasms, spasticity in multiple sclerosis and cerebral palsy Clonazepam - chronic epilepsy

Diazepam or Lorazepam - status epilepticus

Chlordiazepoxide, Clorazepate, Diazepam, Oxazepam - alcohol withdraw related seizures

Page 20: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Anesthesia

• Conscious sedation – Midazolam

• Induction of anesthesia- Midazolam, Lorazepam

• Anxiety provoking and unpleasant procedures- Midazolam

Page 21: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Pharmacokinetics

• Absorption – rapid and complete (lipophilic properties)

• Distribution – throughout the body

• Duration of action – determines use

• Drug fate – metabolized to active compounds

Page 22: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Relationship of Half Life and Indication

Page 23: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Pharmacokinetics - Continued

• BZ’s are lipophilic and they completely absorbed after oral administration.

• Half life's of BZs is very important because the duration of action will determine the therapeutic use.

• Many BZ’s are converted to active metabolites in the body

• Lorazepam and Oxazepam do not form active metabolites. They undergo extrahepatic conjugation

Page 24: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Metabolism

Page 25: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Benzodiazepines Half Life and Age

Page 26: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Dependence

• Psychological and physical – high doses, prolonged periods

• Abrupt discontinuation- withdrawal

• Long half-life – delayed withdrawal

• Short half-life – abrupt, severe withdrawal• Withdrawal Signs- anxiety, confusion, insomnia,

agitation, tremors, hyperreflexia and seizures

Page 27: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Tolerance

• A decrease in responsiveness to repeated dose of the drug when used for more the 1-2 weeks

• Cross tolerance may occur among the different BZs agents.

Page 28: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Rebound

Page 29: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Adverse effects

• Drowsiness and confusion• Ataxia• Cognitive impairment• Decreased long-term recall• Decreased learning

Page 30: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Flumazenil

• Benzodiazepine antagonist• Administered i.v.• Rapid onset, short duration• Withdrawal in dependent patients• May cause seizures• Side effects

Page 31: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Other hypnotic Agents

Page 32: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Other hypnotic agents

• All are hypnotic, selective GABAA agonists

• Zolpidem - not an anticonvulsant or muscle relaxant, fewer adverse effects

• Zaleplon - metabolized in liver, 1hr half-life, reduced dosage in elderly and liver damage

• Eszopiclone – metabolized in liver, 6hr half-life

Page 33: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Ramelteon

• Novel hypnotic for sleep induction • Agonist for MT1 and MT2 receptors• Acts via suprachiasmatic nuclei• No effect on GABAergic system• No rebound insomnia or withdrawal• Rapid absorption, extensive metabolism• Dizziness, somnolence, fatigue• Testosterone decrease, prolactin increase

Page 34: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Other Anxiolytic Agents

• Hydroxyzine- an antihistamine, has low tendency for habituation and thus is useful in patients with anxiety who have history of drug abuse. Also Used in dental procedures

• Antidepressants- SSRI, TCAs MAOI duloxetine venlafaxine all have proven efficacy in managing symptoms of anxiety

Page 35: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Buspirone

• Selective anxiolytic effects, slow onset (weeks)• Serotonin 5-HT1A and dopamine D2 agonist• No direct effect on GABAergic system• No anticonvulsant or muscle relaxant properties. • Low sedative, hypnotic, euphoric effects. Low

abuse potential• No rebound insomnia or withdrawal• Low frequency of side effects

Page 36: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Comparison between Buspirone and Alprazolam

Page 37: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Barbiturates

• Phenobarbital• Pentobarbital• Secobarbital• Amobarbital• Thiopental

Page 38: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Chemical Structures of Barbiturates and Other Hypnotic Drugs

Page 39: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Mechanism of Action

Barbiturates:• Interfere with Na+/K+ transport• Inhibit reticular activating system• Inhibit polysynaptic transmission• Potentiate GABA action on Cl- flux• Bind to subunits other than a and b

Page 40: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Barbiturate classification

• Duration of action:

• Thiopental – fast action, duration ~ 30 min, induction of anesthesia

• Phenobarbital – duration > 1 day, seizure treatment

• Pentobarbital, secobarbital, amobarbital- short acting hypnotics, not anxiolytic

Page 41: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Sedative Hypnotic Dose and CNS Effects

Page 42: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Drug Action

• Depression of CNS – dose dependent sedation, hypnosis, anesthesia, coma and death

• Respiratory depression - suppressed CO2 response

• Porphyria - Barbiturates can increase porphyrin synthesis and are contraindicated in patient with acute intermittent porphyria

Page 43: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Barbiturates and the P-450 Enzyme System

• Barbiturates induce the formation of the liver microsomal enzymes that metabolize drugs.

• The p-450 enzyme induction can lead to multiple drug interactions (e.g. birth control, warfarin, corticosteroids, anti epileptics)

• Barbiturates will decrease the serum level of drugs that are metabolized by P-450 enzymes.

Page 44: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Therapeutic Uses

• Anesthesia – induction of anesthesia selected for duration of

action thiopental, ultra short-acting

• Seizures – tonic-clonic, status epilepticus eclampsia, febrile seizures

• Anxiety - sedation, tension, insomnia, mostly replaced by BZ’s

Page 45: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Pharmacokinetics

• Absorbed orally• Distributed throughout body• Sequential redistribution• Short duration of action (thiopental)• Metabolized in liver• Excreted in urine

Page 46: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Adverse effects

• CNS- confusion, sedation, irritability• Hypotension• Drug hangover• Respiratory depression• Addiction• Poisoning

Page 47: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Non-barbiturate Hypnotics

• Chloral hydrate – acetaldehyde derivative sedative and hypnotic,fast sleep induction,Can displaced warfarin from plasma proteins leading to increase anticoagulant effects

• Antihistamines – diphenhydramine, doxylamine can be used for mild insomnia. Both have undesirable side effects. Can be purchase over-the-counter.

• Ethanol - toxic potential

Page 48: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Drug Interaction with Alcohol

• Alcohol when used with benzodiazepines, antihistamines or barbiturates can produced sever CNS depression

• Alcohol should be avoided when a patient is using a sedative hypnotic agent from the classes above.

Page 49: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Special Populations

• Elderly patients are more sensitive to the effect of sedative-hypnotics

• Doses half of those used in young adults are considered safe and effective for the elderly.

• Increase sensitivity to sedative-hypnotics is also more common in patients with cardiovascular disease, respiratory disease or hepatic impairment

Page 50: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Sedative and Hypnotic Drugs Quiz

Page 51: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Thank you for completing this module

[email protected]

Page 52: Sedative-Hypnotic Drugs Marina Bergman PharmD PhD Lecturer Clinical Generalist – Pharmacist The Ohio State University Wexner Medical Center Marina Bergman.

Survey

We would appreciate your feedback on this module. Click on the button below to complete a brief survey. Your responses and comments will be shared with the module’s author, the LSI EdTech team, and LSI curriculum leaders. We will use your feedback to improve future versions of the module. 

The survey is both optional and anonymous and should take less than 5 minutes to complete.

Survey